Clinical Consultations™: Optimizing Treatment Outcomes for Patients With Cystic Fibrosis

Released On
July 21, 2022

Expires On
July 21, 2023

Media Type
Internet

Completion Time
90 minutes

Specialty
Gastroenterology

Topic(s)
Medication Therapy Management, Rare Diseases, Respiratory

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Vertex Pharmaceuticals.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Nurses — 1.5 Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This educational activity is directed toward health care professionals who treat patients with cystic fibrosis (CF), including CF specialists, pulmonologists, pediatricians, gastroenterologists, nurse practitioners, physician assistants, respiratory therapists, and nurses.

Activity Overview

This Clinical Consultations™ is a video-based program in which 3 experts use a case-based approach to discuss the treatment and management of cystic fibrosis (CF). In this activity, the faculty focus on the current and emerging therapeutic strategies for the management of CF from newborns to adults. This engaging format is designed to help clinicians identify best practices in the diagnosis and management of CF and to improve outcomes for their patients with this disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the pathophysiologic mechanisms underlying cystic fibrosis
  • Identify barriers to diagnosis of cystic fibrosis
  • Analyze clinical trial data for emerging therapies for the treatment of cystic fibrosis
  • Develop multidisciplinary care plans for patients with cystic fibrosis

 

Faculty

FACULTY_NAME

Clement L. Ren, MD, MBA, ATSF

Director, Cystic Fibrosis Center
Division of Pulmonary and Sleep Medicine
Children’s Hospital of Philadelphia
Professor of Pediatrics
Richard B. Johnston, Jr. Endowed Chair in Pediatrics
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

 
FACULTY_NAME

Samya Nasr, MD, CPI, ATSF

Professor of Pediatrics
Director, Cystic Fibrosis Center
University of Michigan Health System
Immediate Past President, Michigan Thoracic Society
Coordinator, State of Michigan CF Newborn Screening Program
Chair, American Thoracic Society International Health Committee
Co-Chair, Michigan Children’s Special Health Care Services
Advisory Committee
Ann Arbor, MI

FACULTY_NAME

George M. Solomon, MD

Associate Professor of Medicine
University of Alabama at Birmingham (UAB) Division of Pulmonary, Allergy, and Critical Care Medicine
Director, UAB Adult PCD and Bronchiectasis Programs
Director, UAB CF Therapeutics Development Network Center
Associate Director, UAB Pulmonary and Critical Care Fellowship
Associate Scientist, Gregory Fleming James CF Research Center
Birmingham, AL


Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Clement L. Ren, MD, MBA, ATSF
  • Grant/Research Support: Vertex Pharmaceuticals clinical trials grants
  • Consultant: Vertex Pharmaceuticals, AbbVie Inc.
Samya Nasr, MD, CPI, ATSF
  • Grant/Research Support: Vertex Pharmaceuticals
  • Consultant: Vertex Pharmaceuticals
George M. Solomon, MD
  • Grant/Research Support: Vertex, Insmed, Electromed, Enterprise, 4DMT, AstraZeneca, Krystal Bio, CFF, NIH
  • Consultant: Spark, Electromed
  • Speakers’ Bureau: Insmed, Electromed

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

Certificates will be emailed to the participant.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.